Louise Chen, specialty pharma analyst at Cantor Fitzgerald, discusses Johnson & Johnson’s path for its potential COVID-19 vaccine, and how that could impact the company’s results.
Fuente: Youtube
Louise Chen, specialty pharma analyst at Cantor Fitzgerald, discusses Johnson & Johnson’s path for its potential COVID-19 vaccine, and how that could impact the company’s results.
Fuente: Youtube